drugset / Trial / NCT02552225

Treatment of Chronic Laryngitis With Amitriptyline

NCT02552225

Phase 2/3 Terminated 6 enrolled Boston Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This randomized, double-blind, placebo-controlled trial will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis.

Timeline

Start
2016-04
Primary completion
2021-01-15
Completion
2021-01-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Amitriptyline Small molecule

Indications